Barclays’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Barclays’s Portfolio RNA Stock Details RNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-113,353	Closed	-$2.04M	–	7511
2014 Q4	$2.04M	Buy	113,353 +60,606	+115%	+$861K	﹤0.01%	2519
2014 Q3	$422K	Buy	52,747 +28,095	+114%	+$266K	﹤0.01%	4089
2014 Q2	$296K	Buy	+24,652	New	+$200K	﹤0.01%	4448
2014 Q1	–	Sell	-17,873	Closed	-$111K	–	7885
2013 Q4	$71K	Buy	+17,873	New	+$81.4K	﹤0.01%	5942

Barclays's RNA Position: Q1 2015 in Review

Barclays sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 113,353 shares — an estimated $2.04M sold.

Barclays first reported a position in RNA in Q4 2013 and held it in 4 quarters. The position peaked at $2.04M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

Barclays reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
Barclays sold 113,353 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $2.04M.
Barclays first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2013 and held it in 4 quarters.
Barclays's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2.04M in Q4 2014.
0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.